Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Chemotherapy, Adjuvant × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Rectal Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Stomach Neoplasms 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Sarcopenia 1 Sarcoglycanopathies 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Microsatellite Instability 1 Mesothelioma 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 HER2 Negative Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Frailty 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡